Aldeyra Therapeutics, Inc. 10-K filing
Filed 2026-02-27 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001193125-26-083012
- Form type
- 10-K
- CIK
- 0001341235
- Primary document
- https://www.sec.gov/Archives/edgar/data/1341235/000119312526083012/aldx-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aldeyra Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-35.3M | - | - |
| Net Income | $-33.8M | - | - |
| Eps Basic | -0.56 | - | - |
| Eps Diluted | -0.56 | - | - |
| Cash And Equivalents | $70.0M | - | - |
| Total Assets | $72.1M | - | - |
| Total Liabilities | $27.8M | - | - |
| Shareholders Equity | $44.3M | - | - |
| Operating Cash Flow | $-33.3M | - | - |